Breaking news: Artemisia afra cures tuberculosis

Artemisia guérit la tuberculose

Tuberculosis kills 2 000 000 people every year. And the situation is dramatic because the disease becomes resistant to conventional pharmaceutical treatments. These take 1-2 years to be efficient. A pilot trial was run at the Ruanguba Hospital in North Kivu Province, Democratic Republic of the Congo to confirm the efficacy of Artemisia Afra as a supplement to the National anti-TB- Treatment 5 patients were admitted with confirmed laboratory Ziehl-Neelsen test on Day 0. All of these patients were adult male with the following symptoms typical to Active tuberculosis: productive cough for more than 3 weeks aggravated at night, chest pain, fatigue, loss of appetite, fever and night sweats. They were given the national program treatment (RHZE) with 10 gm of Artemisia afra (leaves and stems) dissolved in 1 liter of boiled water in 3 divided doses. On day 5, the following symptoms stopped: cough, fatigue, fever and night sweats. On day 7, all the patients were symptoms free and displayed a lot of energy to the point that they asked to visit their fields. They walked for around 10 kms and returned to the hospital with no symptoms. On day 10, all of the patients had sputum laboratory examination and the Ziehl-Neelsen test was negative : total absence of mycobacteria in the sputum of the 5 patients. This in vivo result is to our knowledge the first observed for this combination of Artemisia afra or Artemisia annua infusions combined with conventional anti-tuberculosis drugs. Meanwhile another trial was run in Tanzania with Artemisia annua and Artemisia afra alone, without the pharmaceutical drugs as complement, This trial confirmed the findings from Kivu Artemisia afra, a widespread wild African plant, will save Africa, not only from Malaria, Schistosomiasis, Trypanosoma, but also from Tuberculosis

Posté dans News


L’homme nous passionne, sa diversité, ses histoires, ses savoirs, ses ignorances, sa compréhension du monde

Alexandre Poussin

contactez nous

  • IFBV ASBL (RCS-F4908)
    c/o Kaufhold & Reveillaud
    REFKR QJB0019
    18, avenue Marie-Thérèse
    L-2132 Luxembourg